Apply This IPO

Best Margin

Zero Brokerage

24*7 Customer Support.

Fastest mobile support

---

Apply with Angel One

Apply with Zerodha

Pre-Apply with Upstox

Innova Captab Limited IPO Review

Innova Captab Limited IPO engaged in pharmaceutical company in India involved in every step of the pharmaceutical process, from research and development to manufacturing, distribution, marketing, and exports. They provide CDMO services, handling the commercial production of generic products on a large scale. They team up with their clients through loan license agreements.

Their wide-ranging CDMO capabilities enable their to deliver various drug forms—tablets, liquids, syrups, injectables, and even advanced options like modified release tablets and capsules. Plus, they've embraced new technologies, like nano technology, to enhance their product offerings. Their Competitive Strengths are Leading presence and one of the fastest growing CDMOs in the Indian pharmaceutical formulations market, Theyll established relationships with their marquee CDMO customer base, Highly efficient operations, including their world class manufacturing facilities and supply chain, Rapidly growing domestic and international export branded generics businesses.

Innova Captab Limited Products and Services

innova captab limited a one-stop-shop pharmaceutical company based in India, involved in everything from developing and making drugs to distributing, marketing, and exporting them. Their operations cover various aspects, including manufacturing services for Indian pharmaceutical firms, selling branded generics domestically, and expanding their reach with international branded generics. In the fiscal year 2022, they ranked third in operating revenue among Indian formulation CDMO players,

innova captab ipo branded generics venture, they create, produce, and distribute generic formulation products. These meds, carrying their own brand names, reach Indian consumers through both online and offline channels. Their branded generics are essentially generic medicines with expired patents, sold directly to distributors, stockists, and retailers. Their Strategies Expansion of their manufacturing capacities, Integration of the acquired Sharon business, Expand the wallet share of existing customers and develop new customers, Continued focus on their R&D operations, Growing their international export business, Expanding their domestic branded generics business.

Financial Overview

innova captab private limited company makes generic pharmaceutical products with its own brand for both local and global markets. It's been doing innova cap tab limited, with increasing revenue and profits. The recent acquisition of Sharon Bio by the company is a positive sign for its growth plans. It's also getting ready to introduce new products with a new plant coming up in Jammu. Looking at the earnings for the fiscal year 2024, the stock seems appropriately valued, but there's potential for good returns in the future after the expansion. Investors might consider putting money in for medium to long-term gains.